On-demand education


Prof. Cornford and Dr. Briers discuss the need for patient input in the EAU Guidelines

Duration: Approx. 9min

WHO 2022 Classification of Male Genitourinary Tract tumor: What is relevant? Novelties for the practicing urologist?

Duration: Approx. 60 minutes

PARP Inhibitor in Prostate Cancer. Part III

Duration: 60

New insights in treatment of bladder cancer: From localised to metastatic diseases

Duration: 60

Advanced Prostate Cancer – Non-Metastatic Hormone-Sensitive Prostate Cancer (nmHSPC)

Duration: Approx. 120 minutes

PARP inhibitors in prostate cancer. Part 2

Duration: 70

Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments

Duration: Approx 60 minutes

Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice

Duration: Approx. 50 minutes

Artificial intelligence: The role for research and patient treatment

Duration: Approx. 70 minutes

Patient stratification and risk related treatment of NMIBC

Duration: Approx. 60 minutes

UROwebinar: PARP inhibitors in prostate cancer. Part 1

Duration: Approx. 60 minutes

Robotic Retzius sparing prostatectomy

Duration: 60 min.

Dr. Toine van der Heijden about the three different diversions mentioned in the EAU guidelines after cystectomy

Duration: 10 min

Dr. Oscar Rodriguez Faba talks about how we can improve the organ pool for kidney transplantation

Duration: 5:48 min

Identification and management of patients with nmCRPC

Duration: Approx. 60 – 90 minutes

EAU Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma

Duration: Approx. 60 – 90 minutes